Kolon TissueGene Decides on 47.8 Billion KRW Paid-in Capital Increase
Kolon TissueGene announced on the 23rd that it has decided to conduct a paid-in capital increase worth 47.8 billion KRW to secure operating funds.
The company will issue 762,350 common shares at 62,460 KRW per share through a third-party allotment. The third-party allotment target is Kolon Co., Ltd., the largest shareholder.
Hot Picks Today
Boyfriend Used It for Free, I Had to Pay... Woman in Her 20s Sues Over 'Gender Discrimination' Restroom Fees
- "Was This Delicious Gimbap Only for Koreans?" Sold Out at $28 a Roll... Gimbap Debuts at US Tennis Mecca
- "With Foreign Tourists Flocking to Korea, Calls Grow to Raise Departure Tax Like Hong Kong and Japan... Legislation Gains Speed"
- "We'll Get at Least 30 Million Won a Month"... Cheongdam-dong Landlords Won't Lower Rent Despite Year-Long Vacancies
- "Jeju Should Not Be Taken Lightly... Do Not Walk Alone Even in Broad Daylight," Warns Jeju Resident of 7 Years, Hyegul Hong
Regarding the selection process, the company stated, "The allocation was made considering the investor's intention and payment capability to achieve management objectives and raise funds."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
